Copyright Reports & Markets. All rights reserved.

Global Ketorolac Injection Market Status and Forecast 2021-2027

Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Ketorolac Injection Market Status and Forecast (2016-2027)
      • 1.3.2 Global Ketorolac Injection Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Ketorolac Injection Supply by Company

    • 2.1 Global Ketorolac Injection Sales Volume by Company
    • 2.2 Global Ketorolac Injection Sales Value by Company
    • 2.3 Global Ketorolac Injection Price by Company
    • 2.4 Ketorolac Injection Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Ketorolac Injection Market Status by Type

    • 3.1 Ketorolac Injection Type Introduction
      • 3.1.1 15mg/ml
      • 3.1.2 30mg/ml
    • 3.2 Global Ketorolac Injection Market by Type
      • 3.2.1 Global Ketorolac Injection Sales Volume by Type (2016-2021)
      • 3.2.2 Global Ketorolac Injection Sales Value by Type (2016-2021)
      • 3.2.3 Global Ketorolac Injection Price by Type (2016-2021)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Ketorolac Injection Market Status by Application

    • 4.1 Ketorolac Injection Segment by Application
      • 4.1.1 Hospital
      • 4.1.2 Clinics
      • 4.1.3 Recovery Center
    • 4.2 Global Ketorolac Injection Market by Application
      • 4.2.1 Global Ketorolac Injection Sales Volume by Application (2016-2021)
      • 4.2.2 Global Ketorolac Injection Sales Value by Application (2016-2021)
      • 4.2.3 Global Ketorolac Injection Price by Application (2016-2021)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Ketorolac Injection Market Status by Region

    • 5.1 Global Ketorolac Injection Market by Region
      • 5.1.1 Global Ketorolac Injection Sales Volume by Region
      • 5.1.2 Global Ketorolac Injection Sales Value by Region
    • 5.2 North America Ketorolac Injection Market Status
    • 5.3 Europe Ketorolac Injection Market Status
    • 5.4 Asia Pacific Ketorolac Injection Market Status
    • 5.5 Central & South America Ketorolac Injection Market Status
    • 5.6 Middle East & Africa Ketorolac Injection Market Status

    6 North America Ketorolac Injection Market Status

    • 6.1 North America Ketorolac Injection Market by Country
      • 6.1.1 North America Ketorolac Injection Sales Volume by Country (2016-2021)
      • 6.1.2 North America Ketorolac Injection Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Ketorolac Injection Market Status

    • 7.1 Europe Ketorolac Injection Market by Country
      • 7.1.1 Europe Ketorolac Injection Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Ketorolac Injection Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Ketorolac Injection Market Status

    • 8.1 Asia Pacific Ketorolac Injection Market by Country
      • 8.1.1 Asia Pacific Ketorolac Injection Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Ketorolac Injection Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Ketorolac Injection Market Status

    • 9.1 Central & South America Ketorolac Injection Market by Country
      • 9.1.1 Central & South America Ketorolac Injection Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Ketorolac Injection Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Ketorolac Injection Market Status

    • 10.1 Middle East & Africa Ketorolac Injection Market by Country
      • 10.1.1 Middle East & Africa Ketorolac Injection Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Ketorolac Injection Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Ketorolac Injection Manufacturing Cost Analysis
    • 11.5 Ketorolac Injection Sales Channel and Distributors Analysis
      • 11.5.1 Ketorolac Injection Sales Channel
      • 11.5.2 Ketorolac Injection Distributors
    • 11.6 Ketorolac Injection Downstream Major Buyers

    12 Global Ketorolac Injection Market Forecast by Type and by Application

    • 12.1 Global Ketorolac Injection Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Ketorolac Injection Forecast by Type
      • 12.2.1 Global Ketorolac Injection Sales Volume Forecast by Type
      • 12.2.2 Global Ketorolac Injection Sales Value Forecast by Type
      • 12.2.3 Global Ketorolac Injection Price Forecast by Type
    • 12.3 Global Ketorolac Injection Forecast by Application
      • 12.3.1 Global Ketorolac Injection Sales Volume Forecast by Application
      • 12.3.2 Global Ketorolac Injection Sales Value Forecast by Application
      • 12.3.3 Global Ketorolac Injection Price Forecast by Application

    13 Global Ketorolac Injection Market Forecast by Region/Country

    • 13.1 Global Ketorolac Injection Market Forecast by Region (2022-2027)
      • 13.1.1 Global Ketorolac Injection Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Ketorolac Injection Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Virtus Pharmaceuticals
      • 14.1.1 Company Information
      • 14.1.2 Ketorolac Injection Product Introduction
      • 14.1.3 Virtus Pharmaceuticals Ketorolac Injection Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Sagent
      • 14.2.1 Company Information
      • 14.2.2 Ketorolac Injection Product Introduction
      • 14.2.3 Sagent Ketorolac Injection Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Pfizer
      • 14.3.1 Company Information
      • 14.3.2 Ketorolac Injection Product Introduction
      • 14.3.3 Pfizer Ketorolac Injection Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Hikma
      • 14.4.1 Company Information
      • 14.4.2 Ketorolac Injection Product Introduction
      • 14.4.3 Hikma Ketorolac Injection Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Fresenius Kabi
      • 14.5.1 Company Information
      • 14.5.2 Ketorolac Injection Product Introduction
      • 14.5.3 Fresenius Kabi Ketorolac Injection Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Fosun Pharma
      • 14.6.1 Company Information
      • 14.6.2 Ketorolac Injection Product Introduction
      • 14.6.3 Fosun Pharma Ketorolac Injection Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 BD RX
      • 14.7.1 Company Information
      • 14.7.2 Ketorolac Injection Product Introduction
      • 14.7.3 BD RX Ketorolac Injection Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Athenex
      • 14.8.1 Company Information
      • 14.8.2 Ketorolac Injection Product Introduction
      • 14.8.3 Athenex Ketorolac Injection Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Amphastar
      • 14.9.1 Company Information
      • 14.9.2 Ketorolac Injection Product Introduction
      • 14.9.3 Amphastar Ketorolac Injection Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Alvogen
      • 14.10.1 Company Information
      • 14.10.2 Ketorolac Injection Product Introduction
      • 14.10.3 Alvogen Ketorolac Injection Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Almaject

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Ketorolac Injection market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Ketorolac Injection industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Ketorolac Injection market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Ketorolac Injection Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Ketorolac Injection market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Ketorolac Injection Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Ketorolac Injection industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      15mg/ml
      30mg/ml

      Segmented by Application
      Hospital
      Clinics
      Recovery Center

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Pfizer
      Hikma
      Fresenius Kabi
      Fosun Pharma
      BD RX
      Athenex
      Amphastar
      Alvogen
      Almaject

      Buy now